We are live on
!
Find out more
Vanguard Capital Management Portfolio holdings
AUM
$4.68T
This Fund
S&P 500
This Quarter
Est. Return
+26.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.68T
AUM Growth
+$637B
(+16%)
Cap. Flow
+$33.9B
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
32.56%
Holding
4,163
New
101
Increased
2,575
Reduced
1,196
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HONA
Honeywell Aerospace
HONA
|
+$4.57B |
| 2 |
SPCX
SpaceX
SPCX
|
+$4.51B |
| 3 |
Marvell Technology
MRVL
|
+$3.77B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.69B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$4.59B |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$1.69B |
| 3 |
Salesforce
CRM
|
+$1.28B |
| 4 |
JPMorgan Chase
JPM
|
+$1.15B |
| 5 |
HOLX
Hologic
HOLX
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.14% |
| 2 | Financials | 12.19% |
| 3 | Industrials | 9.6% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Discretionary | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APUS
3926
Apimeds Pharmaceuticals US
APUS
$6.46M
| $57.3K | ﹤0.01% |
6,365
-3,228
| -34% | -$44K |
|
3927
Aptevo Therapeutics
APVO
$4.27M
| $56.4K | ﹤0.01% |
12,713
| – | – |
|
|
ASBP
3928
Aspire Biopharma
ASBP
$10M
| $55.6K | ﹤0.01% |
10,408
+10,146
| +3,873% | +$103K |
|
3929
Pulmatrix
PULM
$5.62M
| $54.9K | ﹤0.01% |
32,294
-1,300
| -4% | -$1.76K |
|
|
AMOD
3930
Alpha Modus Holdings
AMOD
$21.9M
| $54.5K | ﹤0.01% |
12,795
| – | – |
|
3931
XWELL
XWEL
$8.28M
| $53.4K | ﹤0.01% |
51,310
| – | – |
|
|
LNAI
3932
Lunai Bioworks
LNAI
$10.2M
| $52.6K | ﹤0.01% |
16,081
+4,019
| +33% | +$11.1K |
|
3933
Kiora Pharmaceuticals
KPRX
$11.3M
| $52.2K | ﹤0.01% |
19,861
| – | – |
|
3934
SenesTech
SNES
$6.56M
| $51.8K | ﹤0.01% |
34,762
-8,103
| -19% | -$13.2K |
|
3935
VerifyMe
VRME
$8.66M
| $50K | ﹤0.01% |
81,394
| – | – |
|
3936
Xcel Brands
XELB
$5.69M
| $50K | ﹤0.01% |
27,759
+19,983
| +257% | +$40K |
|
3937
a.k.a. Brands
AKA
$120M
| $48.7K | ﹤0.01% |
4,550
| – | – |
|
3938
Acurx Pharmaceuticals
ACXP
$7.09M
| $48.2K | ﹤0.01% |
31,099
| – | – |
|
3939
Mangoceuticals
MGRX
$9.08M
| $46.8K | ﹤0.01% |
123,041
| – | – |
|
|
OLOX
3940
Olenox Industries
OLOX
$3.7M
| $46.3K | ﹤0.01% |
8,461
| – | – |
|
|
ORGN
3941
DELISTED
Origin Materials
ORGN
| $45.4K | ﹤0.01% |
45,892
-109,685
| -71% | -$179K |
|
|
FABC
3942
Fabric.AI Inc
FABC
$18.8M
| $45.2K | ﹤0.01% |
+12,242
| New | +$44.1K |
|
3943
bioAffinity Technologies
BIAF
$3.18M
| $45.1K | ﹤0.01% |
55,543
| – | – |
|
3944
Heart Test Laboratories
HSCS
$8.62M
| $45.1K | ﹤0.01% |
17,968
| – | – |
|
|
AGIG
3945
Abundia Global Impact Group
AGIG
$39.6M
| $45.1K | ﹤0.01% |
45,858
+11,612
| +34% | +$13.2K |
|
3946
Cardio Diagnostics
CDIO
$6.04M
| $44.1K | ﹤0.01% |
20,155
| – | – |
|
3947
PharmaCyte Biotech
PMCB
$5.92M
| $43.7K | ﹤0.01% |
56,778
+5,311
| +10% | +$4K |
|
|
ARAI
3948
Arrive AI Inc
ARAI
$12.9M
| $43.3K | ﹤0.01% |
100,839
+35,498
| +54% | +$23.8K |
|
|
IQST
3949
IQSTEL Inc
IQST
$7.54M
| $42.6K | ﹤0.01% |
36,745
| – | – |
|
|
AMZE
3950
Amaze Holdings
AMZE
$1.55M
| $42.5K | ﹤0.01% |
41,788
+28,222
| +208% | +$34K |
|
Similar funds
Vanguard Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Capital Management held 4,163 positions worth $4.68T, up 16% from $4.04T the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 4.1%. Vanguard Capital Management opened 101 new positions and exited 71, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Vanguard Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 20,693,166 shares worth $4.57B.
- Vanguard Capital Management added most to Marvell Technology in Q2 2026, an estimated $3.77B increase.
- Vanguard Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $4.59B.
- Vanguard Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.69B.
- Vanguard Capital Management's ten largest holdings make up 33% of its $4.68T portfolio in Q2 2026.
- Vanguard Capital Management opened 101 new positions and closed 71 in Q2 2026.
- Vanguard Capital Management's portfolio value rose 16% quarter-over-quarter to $4.68T.
Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.